Fombellida-Lopez, C., Östling Ellen, Aguilar Ortmans, D., DELLOT, P., MARECHAL, N., Vanwinge, C., Cavalier, E., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., Pasternak O. Alexander, & Darcis, G. (10 March 2025). Impact of ART simplification with dolutegravir and lamivudine on the HIV reservoir [Poster presentation]. Conference on Retroviruses and Opportunistic Infection (CROI 2025), San Francisco, United States. |
  | Laverdeur, J., Amory, H., Beckers, P., Desmecht, D., Francis, F., Garigliany, M.-M., Hayette, M.-P., Linden, A., & Darcis, G. (28 January 2025). West Nile and Usutu viruses: current spreading and future threats in a warming northern Europe. Frontiers in Virology, 5. doi:10.3389/fviro.2025.1544884  Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Lambert, N., MASSAGE, P., Meex, C., Hayette, M.-P., Delvenne, P., Rinkin, C., Moutschen, M., Darcis, G., Malaise, O., & Giot, J.-B. (December 2024). Mycobacterium heraklionense: An emerging cause of hand tenosynovitis. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 37, 100479. doi:10.1016/j.jctube.2024.100479 Peer Reviewed verified by ORBi |
Fombellida-Lopez, C., Östling Ellen, Aguilar Ortmans, D., DELLOT, P., MARECHAL, N., Vanwinge, C., Cavalier, E., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., Pasternak O. Alexander, & Darcis, G. (28 November 2024). Impact of ART simplification with dolutegravir and lamivudine on the HIV reservoir [Poster presentation]. Belgium Research on AIDS and HIV Consortium (BREACH 2024), Bruxelles, Belgium. |
  | Bučić, D., Darcis, G., & El Moussaoui, M. (2024). General dermatology and dermatology in primary health care. Clinical and Experimental Dermatology. doi:10.1093/ced/llae512 Peer Reviewed verified by ORBi |
 | Diep, A. N., Schyns, J., Gourzonès, C., Goffin, E., Papadopoulos, I., Moges, S. M., MINNER, F., Bonhomme, G., Paridans, M., Gillain, N., Husson, E., Garigliany, M.-M., Darcis, G., Saegerman, C., Desmecht, D., Guillaume, M., Bureau, F., Donneau, A.-F., & Gillet, L. (07 November 2024). Saliva-based and nasal swab PCR tests of Sars-Cov-2: A longitudinal study on testing agreement and duration of positivity among participants with different Sars-Cov-2 antigen exposures [Paper presentation]. 31th Annual Meeting of the Royal Statistical Society of Belgium, Gent, Belgium. |
 | Polese, B., Ernst, M., Henket, M., Ernst, B., Winandy, M.-L., Njock, M.-S., BLOCKX, C., KOVACS, S., WATAR, F., Peired, A. J., Tomassetti, S., Nardi, C., Gofflot, S., Rahmouni, S., Schofield, J. P., Penrice-Randa, R., Skipp, P. J., Strazzeri, F., Parkinson, E., ... Guiot, J. (2024). Circulating inflammatory cytokines predict severity disease in hospitalized COVID-19 patients: a prospective multicenter study of the European DRAGON consortium. Journal of Infection and Public Health, 102589. doi:10.1016/j.jiph.2024.102589 Peer Reviewed verified by ORBi |
 | Lopez Delhoulle, V.* , Destordeur, L.-C., Maes, N., Fombellida, K., El Moussaoui, M., & Darcis, G.*. (November 2024). Tracing the evolution of polypharmacy and drug-drug interactions in people living with HIV [Poster presentation]. HIV Glasgow 2024, Glasgow, United Kingdom. |
Fombellida-Lopez, C., Östling Ellen, Aguilar Ortmans, D., DELLOT, P., MARECHAL, N., Vanwinge, C., Ladang, A., Cavalier, E., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., Pasternak O. Alexander, & Darcis, G. (23 September 2024). Impact of ART simplification with dolutegravir and lamivudine on the HIV reservoir [Poster presentation]. HIV Cure Symposium 2024, Gand, Belgium. |
 | Nasreddine, R., Darcis, G., Yombi, J. C., De Munter, P., Florence, E., Van Praet, J., Demeester, R., Allard, S. D., Schroeder, M., Dusabineza, A.-C., Delforge, M., & De Wit, S. (June 2024). A characterization of the HIV population with limited/exhausted treatment options: a multicenter Belgian study. Acta Clinica Belgica, 79 (3), 153 - 159. doi:10.1080/17843286.2024.2359184 Peer Reviewed verified by ORBi |
 | Buanec, H. L., Schiavon, V., Merandet, M., How-Kit, A., Bergerat, D., Fombellida-Lopez, C., Bensussan, A., Bouaziz, J.-D., Burny, A., Darcis, G., Song, H., Sajadi, M. M., Kottilil, S., Gallo, R. C., & Zagury, D. (19 March 2024). Early elevated IFNα is a key mediator of HIV pathogenesis. Communications Medicine, 4 (1), 53. doi:10.1038/s43856-024-00454-6 Peer Reviewed verified by ORBi |
 | Le Buanec, H., Schiavon, V., Merandet, M., How-Kit, A., Song, H., Bergerat, D., Fombellida-Lopez, C., Bensussan, A., Bouaziz, J.-D., Burny, A., Darcis, G., Sajadi, M. M., Kottilil, S., Zagury, D., & Gallo, R. C. (19 March 2024). IFNα induces CCR5 in CD4+ T cells of HIV patients causing pathogenic elevation. Communications Medicine, 4 (1), 52. doi:10.1038/s43856-024-00453-7 Peer Reviewed verified by ORBi |
 | Scaia, D., Fombellida, K., Maes, N., El Moussaoui, M., & Darcis, G. (14 March 2024). Risk Factors for Late HIV Presentation in Patients Treated at a Single Belgian Reference Centre from 2018 to 2022. Infectious Disease Reports, 16 (2), 239 - 248. doi:10.3390/idr16020019 Peer Reviewed verified by ORBi Dataset: 10.3390/idr16020019 |
 | Fombellida-Lopez, C., Berkhout, B., Darcis, G., & Pasternak, A. O. (2024). Persistent HIV-1 transcription during ART: time to reassess its significance? Current Opinion in HIV and AIDS. doi:10.1097/COH.0000000000000849 |
 | El Moussaoui, M., Bontems, S., Meex, C., Hayette, M.-P., LEJEUNE, M., Hong, S. L., Dellicour, S., Moutschen, M., CAMBISANO, N., Renotte, N., Bours, V., Darcis, G., Artesi, M.* , & Durkin, K.*. (04 March 2024). Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection. Virus Evolution, 10 (1), 073. doi:10.1093/ve/veae073 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Laverdeur, J., Desmecht, D., Hayette, M.-P., & Darcis, G. (15 January 2024). Dengue and chikungunya: future threats for Northern Europe? Frontiers in Epidemiology, 4. doi:10.3389/fepid.2024.1342723 Peer Reviewed verified by ORBi |
 | Nasreddine, R., Yombi, J. C., Darcis, G., Van Frankenhuijsen, M., Van Petersen, L., Abels, C., Dos Santos Mendes, S., Delforge, M., & De Wit, S. (2024). A Characterization of Women Living with HIV in Belgium. AIDS Research and Treatment, 2024 (1), 5590523. doi:10.1155/2024/5590523 Peer Reviewed verified by ORBi |
 | Paridans, M., Monseur, J., Gillain, N., Husson, E., Darcis, G., Saegerman, C., Gillet, L., Bureau, F., Donneau, A.-F., Guillaume, M.* , & Pétré, B.*. (2024). Impact of the COVID-19 vaccination on confusion around vaccination in general: A longitudinal study on a university population over 18 months. PLOS Global Public Health, 4 (12), 0004066. doi:10.1371/journal.pgph.0004066 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Diep, A. N.* , Schyns, J.* , Gourzonès, C.* , Goffin, E., Papadopoulos, I., Moges, S., MINNER, F., Ek, O., Bonhomme, G., Paridans, M., Gillain, N., Husson, E., Garigliany, M.-M., Darcis, G., Saegerman, C., Desmecht, D., Guillaume, M.* , Donneau, A.-F.* , Bureau, F.* , & Gillet, L.*. (2023). How do successive vaccinations and SARS-CoV-2 infections impact humoral immunity dynamics: an 18-month longitudinal study [letter to the editor]. Journal of Infection. doi:10.1016/j.jinf.2023.11.006 Editorial reviewed* These authors have contributed equally to this work. |
 | Callewaert, C., Pezavant, M., Vandaele, R., Meeus, B., Vankrunkelsven, E., Van Goethem, P., Plumacker, A., Misset, B., Darcis, G., PIRET, S., De Vleeschouwer, L., Staelens, F., Van Varenbergh, K., Tombeur, S., Ottevaere, A., Montag, I., Vandecandelaere, P., Jonckheere, S., Vandekerckhove, L., ... Guyot, H. (19 September 2023). Sniffing out safety: canine detection and identification of SARS-CoV-2 infection from armpit sweat. Frontiers in Medicine, 10. doi:10.3389/fmed.2023.1185779 Peer Reviewed verified by ORBi |
 | Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (11 September 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. HIV Cure Symposium 2023, Gand, Belgium. |
 | Vossius, G., Meex, C., Moerman, F., THYS, M., Ernst, M., Bourgeois, M.-E., Wagner, L., DELAHAYE, T., & Darcis, G. (11 September 2023). Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single-Center Retrospective Study. Pathogens (Basel, Switzerland), 12 (9), 1152. doi:10.3390/pathogens12091152 Peer reviewed |
 | COVID-19 Host Genetics Initiative, Rahmouni, S., Georges, M., Moutschen, M., Darcis, G., & Beguin, Y. (September 2023). A second update on mapping the human genetic architecture of COVID-19. Nature, 621 (7977), 7 - E26. doi:10.1038/s41586-023-06355-3 Peer Reviewed verified by ORBi Dataset: 10.1038/s41586-023-06355-3 |
 | Llucià-Carol, L., Elena Muiño, Natalia Cullell, Jara Cárcel-Márquez, Miquel Lledós, Cristina Gallego-Fabrega, Jesús Martin-Campos, Joan Martí-Fàbregas, Ana Aguilera-Simón, Anna M. Planas, Marta L. DeDiego, Alicia de Felipe Mimbrera, Jaime Masjuan, Sebastián García-Madrona, Tomás Segura, Esther González-Villar, Gemma Serrano-Heras, Ana Domínguez Mayoral, Paloma Menéndez-Valladares, ... Israel Fernández-Cadenas. (30 August 2023). Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes. International Journal of Molecular Sciences, 24 (17). doi:10.3390/ijms241713452 Peer Reviewed verified by ORBi Dataset: 10.3390/ijms241713452 |
 | Lambert, N., El Moussaoui, M., Baron, F., Maquet, P., & Darcis, G. (06 July 2023). Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review. Viruses, 15 (7), 1510. doi:10.3390/v15071510 Peer Reviewed verified by ORBi |
 | Kremer, C., Torneri, A., Libin, P. J. K., Meex, C., Hayette, M.-P., Bontems, S., Durkin, K. W., Artesi, M., Bours, V., Lemey, P., Darcis, G., Hens, N., & Meuris, C. (16 June 2023). Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data. Epidemics, 44, 100701. doi:10.1016/j.epidem.2023.100701 Peer Reviewed verified by ORBi |
 | Le Buanec, H., Schiavon, V., Merandet, M., How-Kit, A., Song, H., Bergerat, D., Fombellida-Lopez, C., Bensussan, A., Bouaziz, J.-D., Burny, A., Darcis, G., Sajadi, M. M., Kottilil, S., Zagury, D., & Gallo, R. C. (2023). IFNα induces CCR5 in CD4+ T-cells, causing its anti- HIV inefficiency and its subsequent pathogenic elevation, partially controlled by anti-HIV therapy. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/308342. doi:10.21203/rs.3.rs-2813616/v1 |
 | Le Buanec, H., Schiavon, V., Merandet, M., How-Kit, A., Bergerat, D., Fombellida-Lopez, C., Bensussan, A., Bouaziz, J.-D., Burny, A., Darcis, G., Song, H., Sajadi, M. M., Kottilil, S., Gallo, R. C., & Zagury, D. (2023). Early Elevated IFNα Identified as the Key Mediator of HIV Pathogenesis and its low level a Hallmark of Elite Controllers. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/308341. doi:10.21203/rs.3.rs-2813601/v1 |
 | El Moussaoui, M., Guiot, J., FRIPPIAT, F., & Darcis, G. (May 2023). Une cause émergente de fatigue et de douleurs chroniques : l’affection post-COVID-19 ou COVID long. Revue Médicale de Liège, 78 (5-6), 299 - 304. Editorial Reviewed verified by ORBi |
 | Nasreddine, R., Florence, E., Yombi, J. C., Henrard, S., Darcis, G., Van Praet, J., Vandekerckhove, L., Allard, S. D., Demeester, R., Messiaen, P., Ausselet, N., Delforge, M., De Wit, S., & Belgian Research on AIDS and HIV Consortium (BREACH). (2023). Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium. HIV Medicine. doi:10.1111/hiv.13493 Peer Reviewed verified by ORBi |
 | de Crane D'Heysselaer, S., Parisi, G., Lisson, M., Bruyère, O., Donneau, A.-F., Fontaine, S., Gillet, L., Bureau, F., Darcis, G., Thiry, E., Ducatez, M., Snoeck, C. J., Zientara, S., Haddad, N., Humblet, M.-F., Ludwig-Begall, L., Daube, G., Thiry, D., Misset, B., ... Haubruge, E. (27 February 2023). Systematic Review of the Key Factors Influencing the Indoor Airborne Spread of SARS-CoV-2. Pathogens, 12 (3), 382. doi:10.3390/pathogens12030382 Peer reviewed |
 | Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (21 February 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Conference on Retroviruses and Opportunistic Infection (CROI 2023), Seattle, United States. |
 | Van Praet, J. T., Serrien, B., Ausselet, N., Darcis, G., Demeester, R., De Munter, P., De Scheerder, M.-A., Goffard, J.-C., Libois, A., Messiaen, P., Yombi, J. C., Van Beckhoven, D., & Belgian HIV Cohort Study Group. (14 February 2023). Dynamics of weight change after initiation of contemporaneous antiretroviral therapy in treatment-naive HIV-1 patients: results from the Belgian HIV Cohort 2015-2021. Journal of Acquired Immune Deficiency Syndromes, 93 (2), 4 - E5. doi:10.1097/QAI.0000000000003175 Peer Reviewed verified by ORBi |
 | Meuris, C., Darcis, G., Orban, C., Hayette, M.-P., Meex, C., Desmecht, D., & Bours, V. (2023). Study of asymptomatic rectal carriage of Monkeypox virus in men who have sex with men, and immunological answer to vaccination, followed in Liège University Hospital. https://orbi.uliege.be/handle/2268/298473 |
 | Mayasi Ngongo, N., Kamangu Ntambwe, E., Situakibanza Nani-Tuma, H., Mbula Mambimbi, M., Mandina Ndona, M., Longokolo Mashi, M., Bepouka Izizag, B., Lukiana, T., Odio Ossam, J., Mangala Sonzi, D., Maes, N., Moutschen, M., El Moussaoui, M., & Darcis, G. (2023). Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013-2020. Open Forum Infectious Diseases, 10 (6), 2-7. doi:10.1093/ofid/ofad242 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435 Peer Reviewed verified by ORBi Dataset: 10.3390/v15071435 |
 | Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (23 November 2022). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Belgium Research on AIDS and HIV Consortium (BREACH 2022), Bruxelles, Belgium. |
 | Paridans, M., Monseur, J., Donneau, A.-F., Gillain, N., Husson, E., Leclercq, D., Meuris, C., Darcis, G., Moutschen, M., Saegerman, C., Gillet, L., Bureau, F., Guillaume, M., & Pétré, B. (2022). The Dynamic Relationship between the Intention and Final Decision for the COVID-19 Booster: A Study among Students and Staff at the University of Liège, Belgium. Vaccines. doi:10.3390/vaccines10091485 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006 Peer Reviewed verified by ORBi |
El Moussaoui, M., Maes, N., Fombellida, K., VAIRA, D., Moutschen, M., & Darcis, G. (02 September 2022). Impact de la pandémie de Covid-19 sur les soins de santé des personnes vivant avec le VIH à Liège, Belgique [Paper presentation]. Congrès annuel de l'Association Latine pour l'Analyse des Systèmes de Santé (CALASS), Barcelone, Spain. Peer reviewed |
 | Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7 Peer Reviewed verified by ORBi Dataset: 10.1038/s41586-022-04826-7 |
 | Cruz, R., Almeida, S. D.-D., Heredia, M. L., Quintela, I., Ceballos, F. C., Pita, G., Lorenzo-Salazar, J. M., González-Montelongo, R., Gago-Domínguez, M., Porras, M. S., Castaño, J. A. T., Nevado, J., Aguado, J. M., Aguilar, C., Aguilera-Albesa, S., Almadana, V., Almoguera, B., Alvarez, N., Andreu-Bernabeu, Á., ... Carracedo, Á. (2022). Novel genes and sex differences in COVID-19 severity. Human Molecular Genetics. doi:10.1093/hmg/ddac132 Peer Reviewed verified by ORBi Dataset: 10.1093/hmg/ddac132 |
 | El Moussaoui, M., Maes, N., Hong, S. L., Lambert, N., Gofflot, S., DELLOT, P., Belhadj, Y., Huynen, P., Hayette, M.-P., Meex, C., Bontems, S., Defêche, J., Godderis, L., Molenberghs, G., Meuris, C., Artesi, M., Durkin, K., Rahmouni, S., GREGOIRE, C., ... DARCIS, G. (14 June 2022). Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium. Viruses, 14 (6), 1302. doi:10.3390/v14061302 Peer Reviewed verified by ORBi Dataset: 10.3390/v14061302 |
 | Mayasi, N., Situakibanza, H., Mbula, M., Longokolo, M., Maes, N., Bepouka, B., Ossam, J. O., MOUTSCHEN, M., & DARCIS, G. (11 March 2022). Retention in care and predictors of attrition among HIV-infected patients who started antiretroviral therapy in Kinshasa, DRC, before and after the implementation of the ‘treat-all’ strategy. PLOS Global Public Health, 2 (3), 0000259. doi:10.1371/journal.pgph.0000259 Peer reviewed |
 | Kousathanas, A., Pairo-Castineira, E., Rawlik, K., Stuckey, A., Odhams, C. A., Walker, S., Russell, C. D., Malinauskas, T., Wu, Y., Millar, J., Shen, X., Elliott, K. S., Griffiths, F., Oosthuyzen, W., Morrice, K., Keating, S., Wang, B., Rhodes, D., Klaric, L., ... LAMBERMONT, B. (Other coll.). (2022). Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature. doi:10.1038/s41586-022-04576-6 Peer Reviewed verified by ORBi |
 | Van Beckhoven, D., Serrien, B., Montourcy, M., Verhofstede, C., Van den Bossche, D., Libois, A., De Geyter, D., Martin, T., Van den Eynde, S., Vuylsteke, B., Darcis, G., van Halem, K., Florence, E., Deblonde, J., Ausselet, N. (Other coll.), Delforge, M.-L. (Other coll.), Demeester, R. (Other coll.), De Munter, P. (Other coll.), Goffard, J.-C. (Other coll.), ... Yombi, J.-C. (Other coll.). (2022). Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care. BMC Infectious Diseases, 22 (1), 901. doi:10.1186/s12879-022-07879-1 Peer Reviewed verified by ORBi |
 | Desmecht, S.* , Tashkeev, A.* , El Moussaoui, M., MARECHAL, N., Perée, H., Tokunaga, Y., Fombellida-Lopez, C., Polese, B., Legrand, C., Wéry, M., Mni, M., Fouillien, N., TOUSSAINT, F., Gillet, L., Bureau, F., LUTTERI, L., HAYETTE, M.-P., MOUTSCHEN, M., MEURIS, C., ... DARCIS, G.*. (2022). Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and -experienced subjects: impact of booster dose and breakthrough infections. Frontiers in Immunology, 13, 863554. doi:10.3389/fimmu.2022.863554 Peer Reviewed verified by ORBi Dataset: 10.1038/s41586-022-04769-z* These authors have contributed equally to this work. |
 | Donneau, A.-F.* , Guillaume, M.* , BOURS, V., Dandoy, M., DARCIS, G., Desmecht, D., Diep, A. N., Fievez, L., Garigliany, M.-M., Gillain, N., Husson, E., Michel, F., MOUTSCHEN, M., Paridans, M., Pétré, B., Sabatel, C., Saegerman, C., Tytgat, A., Gillet, L.* , & Bureau, F.*. (2022). University population-based prospective cohort study of SARS-CoV- 2 infection and immunity (SARSSURV-ULiège): a study protocol. BMJ Open. doi:10.1136/bmjopen-2021-055721 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Cambier, M., Henket, M., Frix, A.-N., Gofflot, S., THYS, M., Tomasetti, S., Peired, A., Struman, I., Rousseau, A.-F., Misset, B., Darcis, G., Moutschen, M., Louis, R., Njock, M.-S., Cavalier, E., & Guiot, J. (2022). Increased KL-6 levels in moderate to severe COVID-19 infection. PLoS ONE, 17 (11), 0273107. doi:10.1371/journal.pone.0273107 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Lambert, N., MAES, N., Fombellida, K., VAIRA, D., MOUTSCHEN, M., & DARCIS, G. (30 November 2021). Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium [Poster presentation]. BREACH Symposium 2021, Bruxelles, Belgium. |
 | Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Lambert, N., MAES, N., Fombellida, K., VAIRA, D., MOUTSCHEN, M., & DARCIS, G. (2021). Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium. HIV Research & Clinical Practice. doi:10.1080/25787489.2021.1948773 Peer Reviewed verified by ORBi |
 | Gregoire, E., Pirotte, B. F., Moerman, F., Altdorfer, A., Gaspard, L., Firre, E., Moonen, M., Fraipont, V., ERNST, M., & DARCIS, G. (2021). Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study. Pathogens (Basel, Switzerland), 10 (11). doi:10.3390/pathogens10111370 Peer reviewed |
 | Darcis, G., Bouquegneau, A., Maes, N., Thys, M., Henket, M., Labye, F., Rousseau, A.-F., Canivet, P., Desir, C., Calmes, D., Schils, R., De Worm, S., Léonard, P., Meunier, P., Moutschen, M., Louis, R., & Guiot, J. (2021). Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. International Journal of Infectious Diseases, 109, 209-216. doi:10.1016/j.ijid.2021.07.016 Peer reviewed |
 | Ngongo, N. M., Nani-Tuma, H. S., Mambimbi, M. M., Mashi, M. L., Izizag, B. B., Ndolumingu, F. K., Maes, N., Moutschen, M., & Darcis, G. (2021). Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020. AIDS Research and Therapy, 18 (1), 41. doi:10.1186/s12981-021-00366-8 Peer Reviewed verified by ORBi |
 | Plum, P.-E., Maes, N., Sauvage, A.-S., Frippiat, F., Meuris, C., Uurlings, F., Lecomte, M., Léonard, P., Paquot, N., Fombellida, K., Vaira, D., Moutschen, M., & Darcis, G. (2021). Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV. BMC Infectious Diseases, 21 (1), 910. doi:10.1186/s12879-021-06479-9 Peer Reviewed verified by ORBi |
 | Defêche, J., AZARZAR, S., Mesdagh, A., DELLOT, P., Tytgat, A., Bureau, F., Gillet, L., Belhadj, Y., BONTEMS, S., HAYETTE, M.-P., Schils, R., Rahmouni, S., ERNST, M., MOUTSCHEN, M., & DARCIS, G. (2021). In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2. Pathogens (Basel, Switzerland), 10 (11). doi:10.3390/pathogens10111362 Peer reviewed |
 | Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x Peer Reviewed verified by ORBi |
 | Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., ... Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757 Peer Reviewed verified by ORBi |
 | Plum, P.-E., Darcis, G., & Moutschen, M. (2021). L’arrivée des bithérapies dans le traitement du virus de l’immunodéficience humaine : la fin d’un dogme? Revue Médicale de Liège, 76 (9), 677 - 682. Editorial Reviewed verified by ORBi |
 | Ngongo, N. M., Darcis, G., Nanituna, H. S., Mambimbi, M. M., Maes, N., Mashi, M. L., Bepouka Izizag, B., Moutschen, M., & Lepira Bompeka, F. (2021). Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017. PLoS ONE, 16 (11), 0259073. doi:10.1371/journal.pone.0259073 Peer Reviewed verified by ORBi |
 | Ngongo, N. M., Nani-Tuma, H. S., Mambimbi, M. M., Mashi, M. L., Izizag, B. B., Maes, N., Moutschen, M., & Darcis, G. (2021). Progressive phasing out of baseline CD4+ cell count testing for people living with HIV in Kinshasa, Democratic Republic of the Congo. AIDS (London, England), 35 (5), 841-843. doi:10.1097/QAD.0000000000002802 Peer reviewed |
 | BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1 Peer Reviewed verified by ORBi |
 | Fombellida-Lopez, C., Chaslain, A., SUSIN, F., VAIRA, D., Moutschen, M., & DARCIS, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 1 : les réservoirs latents. Revue Médicale de Liège, 75 (9), 573-577. Peer reviewed |
 | Chaslain, A., Fombellida-Lopez, C., SUSIN, F., VAIRA, D., Moutschen, M., & Darcis, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 2 : la réplication continue malgré le traitement. Revue Médicale de Liège, 75 (9), 582-587. Peer reviewed |
 | Darcis, G., Berkhout, B., & Pasternak, A. O. (2020). Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs. Viruses, 12 (5). doi:10.3390/v12050489 Peer Reviewed verified by ORBi |
 | Darcis, G., Kootstra, N. A., Hooibrink, B., van Montfort, T., Maurer, I., Groen, K., Jurriaans, S., Bakker, M., van Lint, C., Berkhout, B., & Pasternak, A. O. (2020). CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency. Cell Reports, 30 (7), 2284-2296.e3. doi:10.1016/j.celrep.2020.01.071 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., Moutschen, M., & Darcis, G. (2020). Evolution of Drug Interactions With Antiretroviral Medication in People With HIV. Open Forum Infectious Diseases, 7 (11), 416. doi:10.1093/ofid/ofaa416 Peer Reviewed verified by ORBi |
 | DARCIS, G., VAIRA, D., & MOUTSCHEN, M. (2020). Impact of coronavirus pandemic and containment measures on HIV diagnosis. Epidemiology and Infection. doi:10.1017/S0950268820001867 Peer Reviewed verified by ORBi |
 | Ait-Ammar, A., Kula, A., DARCIS, G., Verdikt, R., De wit, S., Gautier, V., Mallon, P., Marcello, A., Rohr, O., & Van Lint, C. (2020). Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs. Frontiers in Microbiology. doi:10.3389/fmicb.2019.03060 Peer Reviewed verified by ORBi |
 | Ilbert, C., SABATIELLO, M., KURTH, W., Longrée, L., MOUTSCHEN, M., & DARCIS, G. (2020). Le syndrome de Schnitzler. Revue Médicale de Liège. Peer reviewed |
 | El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., FOMBELLIDA, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (22 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Poster presentation]. 8th BREACH SYMPOSIUM, Liège, Belgium. |
El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (08 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Paper presentation]. 17th European AIDS Conference, Bâle, Switzerland. |
 | Verdikt, R., DARCIS, G., Ait-Ammar, A., & Van Lint, C. (2019). Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence. Current Opinion in Virology. doi:10.1016/j.coviro.2019.07.004 Peer Reviewed verified by ORBi |
 | Pirotte, B., FRIPPIAT, F., DARCIS, G., Rassenfosse, M., Fombellida, K., MAES, N., Moerman, F., & MOUTSCHEN, M. (2019). Etude des motifs d'admission au service des Urgences d'une cohorte de patients. Revue Médicale de Liège. Peer reviewed |
 | Kula, A., Delacourt, N., Bouchat, S., DARCIS, G., Avettand-Fenoel, V., Verdikt, R., Corazza, F., Necsoi, C., Vanhulle, C., Benmoudou, M., Burny, A., de Wit, S., Rouzioux, C., Rohr, O., & Van Lint, C. (2019). Heterogeneous HIV-1 reactivation patterns of disulfiram and combined disulfiram+romidepsin treatments. Journal of Acquired Immune Deficiency Syndromes. doi:10.1097/QAI.0000000000001958 Peer Reviewed verified by ORBi |
 | Van Montfort, T., Van der sluis, R., DARCIS, G., Beaty, D., Groen, K., Pasternak, A., Pollakis, G., Vink, M., Westerhout, E., Hamdi, M., Bakker, M., Van Der Putten, B., Jurriaans, S., Prins, J., Jeeninga, R., Thomas, A., Speijer, D., & Berkhout, B. (2019). Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway. EBioMedicine. doi:10.1016/j.ebiom.2019.02.014 Peer Reviewed verified by ORBi |
 | DARCIS, G., Binda, C., Klaver, B., Herrera-Carrillo, E., Berkhout, B., & Das, A. (2019). The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape. Viruses. doi:10.3390/v11030255 Peer Reviewed verified by ORBi |
 | Cimpaye, O., Louis, R., Darcis, G., Beaudart, C., & MEURIS, C. (2019). Evaluation de l'application des recommandations du Conseil Supérieur de la Santé relatives à l'isolement respiratoire des malades atteints de la tuberculose pulmonaire au CHU de Liège. Revue Médicale de Liège, 74 (9), 465-470. Peer reviewed |
 | DARCIS, G., Berkhout, B., & Pasternak, A. (2019). The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like. Frontiers in Immunology. doi:10.3389/fimmu.2019.02251 Peer Reviewed verified by ORBi |
 | DARCIS, G., MAES, N., Pasternak, A., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., El Moussaoui, M., Fombellida, K., VAIRA, D.* , & MOUTSCHEN, M.*. (2019). Detectability of HIV residual Viremia despite therapy is highly associated with treatment with a protease inhibitor-based combination antiretroviral therapy. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.01902-19 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Moreno, S., Perno, C., Mallon, P., Berhens, G., Corbeau, P., Routy, J., & DARCIS, G. (2019). Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch? HIV Medicine. doi:10.1111/hiv.12716 Peer Reviewed verified by ORBi |
 | DARCIS, G., Lambert, I., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., GIOT, J.-B., fombellida, K., VAIRA, D., & MOUTSCHEN, M. (2018). Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017. Scientific Reports. doi:10.1038/s41598-018-26852-0 Peer Reviewed verified by ORBi |
 | DARCIS, G., Van Driessche, B., Bouchat, S., Kirchhoff, F., & Van Lint, C. (2018). Molecular Control of HIV and SIV Latency. Current Topics in Microbiology and Immunology. doi:10.1007/82_2017_74 Peer Reviewed verified by ORBi |
 | DARCIS, G., & Berkhout, B. (2018). Human Immunodeficiency Virus Resistance to Dolutegravir: Are We Looking in the Wrong Place? Journal of Infectious Diseases. doi:10.1093/infdis/jiy474 Peer Reviewed verified by ORBi |
 | DARCIS, G., & Moutschen, M. (2018). Wild-type HIV infection despite PrEP: a lot to learn from a case report. The Lancet HIV, 5 (1), 10. doi:10.1016/S2352-3018(17)30212-6 Peer Reviewed verified by ORBi |
DARCIS, G. (2018). 2 drug combinations: unanswered questions HIV reservoirs [Paper presentation]. GILEAD symposium, Berlin, Germany. |
 | DARCIS, G., Das, A. T., & Berkhout, B. (2018). Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies. Viruses. doi:10.3390/v10040157 Peer Reviewed verified by ORBi |
 | Khoury, G.* , Darcis, G.* , Lee, M., Bouchat, S., Van Driessche, B., Purcell, D. F.* , & Van Lint, C.*. (2018). The Molecular Biology of HIV Latency. Advances in Experimental Medicine and Biology. doi:10.1007/978-981-13-0484-2_8 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | DE VOEGHT, A., Martens, H., RENARD, J. D. C., VAIRA, D., Debruche, M., Simonet, J., Geenen, V., MOUTSCHEN, M., & DARCIS, G. (2017). Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium. PLoS ONE. doi:10.1371/journal.pone.0185761 Peer Reviewed verified by ORBi |
 | DARCIS, G., Van der Auwera, G., GIOT, J.-B., Hayette, M.-P., Tassin, F., Arrese Estrada, J., Cnops, L., Moutschen, M., de Leval, L., & LEONARD, P. (07 July 2017). Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC Infectious Diseases, 17. doi:10.1186/s12879-017-2571-x Peer Reviewed verified by ORBi |
 | DARCIS, G., Bouchat, S., Kula, A., Van Driessche, B., Delacourt, N., Vanhulle, C., Avettand-Fenoel, V., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2017). Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir. AIDS, 31 (2), 181-189. doi:10.1097/QAD.0000000000001290 Peer Reviewed verified by ORBi |
 | DARCIS, G., Van Driessche, B., & Van Lint, C. (2017). HIV Latency: Should We Shock or Lock? Trends in Immunology, 38 (3), 217-228. doi:10.1016/j.it.2016.12.003 Peer Reviewed verified by ORBi |
 | DARCIS, G., & Moutschen, M. (2017). Guérir l'infection par le VIH: Un objectif réaliste? Revue Médicale de Liège, 72 (9), 388-392. Peer reviewed |
 | DARCIS, G., & Moutschen, M. (2017). The effect of treatment simplification on HIV reservoirs. The Lancet HIV, 4 (8), 328-e329. doi:10.1016/S2352-3018(17)30135-2 Peer Reviewed verified by ORBi |
 | Gama, L., Abreu, C., Shirk, E., Price, S., Li, M., Laird, G., Pate, K., Wietgrefe, S., O'Connor, S., Pianowski, L., Haase, A., Van Lint, C., Siliciano, R., Clements, J., Queen, S., Bullock, B., Croteau, J., Pianowski, L., Gellerup, D., ... Mankowski, J. (2017). Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. AIDS. doi:10.1097/QAD.0000000000001267 Peer Reviewed verified by ORBi |
 | Bouchat, S., Verdikt, R., Delacourt, N., Vanhulle, C., Van Driessche, B., DARCIS, G., Pasternak, A., Avettand-Fenoel, V., Ledouce, V., Bendoumou, M., Schwartz, C., De Wit, S., Berkhout, B., Gautier, V., Rouzioux, C., Rohr, O., & Van Lint, C. (2017). Identification of a new factor involved in DNA methylation-mediated repression of latent HIV-1. Journal of the International AIDS Society. |
 | Gunter, J., Callens, S., De Wit, S., Goffard, J.-C., Moutschen, M., DARCIS, G., MEURIS, C., van den Bulcke, C., Fombellida, K., del Forge, M., Razavi, H., & Wyndham-Thomas, C. (2017). Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study. Acta Clinica Belgica, 1-4. doi:10.1080/17843286.2017.1339965 Peer Reviewed verified by ORBi |
 | DARCIS, G., Hayette, M.-P., BONTEMS, S., SAUVAGE, A.-S., MEURIS, C., Van Esbroeck, M., & LEONARD, P. (March 2016). Louse-borne relapsing fever in a refugee from Somalia arriving in Belgium. Journal of Travel Medicine, 23 (3). doi:10.1093/jtm/taw009 Peer Reviewed verified by ORBi |
 | DARCIS, G., Coombs, R. W., & Van Lint, C. (2016). Exploring the anatomical HIV reservoirs: Role of the testicular tissue. AIDS, 30 (18), 2891-2893. doi:10.1097/QAD.0000000000001281 Peer Reviewed verified by ORBi |
 | SAUVAGE, A.-S., DARCIS, G., & Moutschen, M. (2016). Actualité thérapeutique dans le VIH: Le ténofovir alafénamide. Revue Médicale Suisse, 12 (527), 1367-1369. Peer Reviewed verified by ORBi |
DARCIS, G., Bouchat, S., Kula, A., Van Driessche, B., Delacourt, N., Vanhulle, C., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2016). Reactivation capacity by latency reversing agents ex vivo correlates with the size [Paper presentation]. 1st EU4HIVCURE symposium in University College Dublin. |
 | DARCIS, G., Bouchat, S., Kula, A., Van Driessche, B., Delacourt, N., Vanhulle, C., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2016). Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir. International Journal on Advances in Life Sciences. |
 | DARCIS, G., Van Driessche, B., & Van Lint, C. (2016). Preclinical shock strategies to reactivate latent HIV-1: An update. Current Opinion in HIV and AIDS, 11 (4), 388-393. doi:10.1097/COH.0000000000000288 Peer reviewed |
 | Bouchat, S., Delacourt, N., Kula, A., DARCIS, G., Van Driessche, B., Corazza, F., GATOT, J.-S., Melard, A., Vanhulle, C., Kabeya, K., Pardons, M., Avettand-Fenoel, V., Clumeck, N., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2016). Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1. EMBO Molecular Medicine. doi:10.15252/emmm.201505557 Peer Reviewed verified by ORBi |
 | DARCIS, G., Kula, A., Bouchat, S., Fujinaga, K., Corazza, F., Ait-Ammar, A., Delacourt, N., Melard, A., Kabeya, K., Vanhulle, C., Van Driessche, B., GATOT, J.-S., Cherrier, T., Pianowski, L. F., Gama, L., Schwartz, C., Vila, J., Burny, A., Clumeck, N., ... Van Lint, C. (2015). An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression. PLoS Pathogens, 11 (7), 1005063. doi:10.1371/journal.ppat.1005063 Peer Reviewed verified by ORBi |
 | Kumar, A.* , DARCIS, G.* , Van Lint, C., & Herbein, G. (2015). Epigenetic control of HIV-1 post integration latency: Implications for therapy. Clinical Epigenetics, 7 (1). doi:10.1186/s13148-015-0137-6 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Clumeck, N., Rohr, O., MOUTSCHEN, M., Corrazza, F., Rouzioux, C., De Wit, S., & Van Lint, C. (2014). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-kB signaling pathway [Paper presentation]. 20th AIDS international conference, Melbourne, Australia. |
DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Herbein, G., Clumeck, N., Rohr, O., MOUTSCHEN, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2013). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-B signaling pathway [Paper presentation]. First annual meeting Belgian Society for Virology. |
DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Herbein, G., Clumeck, N., Rohr, O., MOUTSCHEN, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2013). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-B signaling pathway [Paper presentation]. 14th European AIDS Conference (EACS), Brussels. |
 | Witvrouw, N., Darcis, G., Gaudray, G., Schaaf-Lafontaine, N., Hustinx, R., Meuris, C., Schepers, K., & Moutschen, M. (2009). A 14-day treatment with a cyclooxygenase 2 (COX-2) inhibitor reduces inflammation in the lymphoid tissues of HIV-infected patients without HAART - a pilot study with positron emission tomography (PET/CT) assessment [Paper presentation]. International AIDS Society 2009 Cape Town, South Africa, Cape Town, South Africa. Peer reviewed |
